![](/_next/image?url=%2Fbanner-fallback.jpg&w=3840&q=90)
Biocarn®
![](/_next/image?url=https%3A%2F%2Fmedice.com%2Fapi%2Fen-de%2Four-products%2Frevitalization%2Fbiocarn-r%2F%40%40images%2F8f3dd166-4c3c-43ae-ae9e-df9ccf05bf4e.jpeg&w=3840&q=90)
Therapeutic indications
- as substitution therapy for primary and secondary systemic carnitine deficiency.
- as an attempted treatment of special forms of muscular dystrophy and lipid accumulation associated with primary muscle carnitine deficiency.
- to complement the treatment of progressive Duchenne muscular dystrophy, if functioning skeletal muscle is still present.
Biocarn 1 g levocarnitine/3.3 ml syrup Therapeutic indications: As substitution therapy for primary and secondary systemic carnitine deficiency; as an attempted treatment of special forms of muscular dystrophy (muscle wasting) and lipid accumulation (build up of fats) associated with primary muscle carnitine deficiency; to complement the treatment of progressive Duchenne muscular dystrophy, if functioning skeletal muscle is still present; to compensate for levocarnitine losses resulting from dialysis in chronic haemodialysis. For the risks and adverse reactions, read the package insert and consult your doctor or pharmacist.